May 11, 2018—While the 340B drug pricing program played a minor supporting role in President Trump’s drug pricing announcements today, it is certain to engender significant debate in the months ahead. The announcements made today no new policy proposals but did continue rhetorical attacks on the program. The President never uttered the words “340B” but did reference the … [Read more...]
Drug Prices Continue to Soar and the Public Notices
March 27, 2018—A trio of new reports out this past week indicates that the historic rise in prescription drug prices in the U.S. continues and the American public is concerned. First, a report by Axios found the prices of the top 20 drugs prescribed in the U.S. rose by more than 200 percent in the past 14 months. Based on an analysis by Pharmacy Benefits Consultants, Axios … [Read more...]
PhRMA-Funded Study Contradicts Its Conclusions
March 19, 2018 – A new PhRMA-funded study released by Milliman suggests that 340B hospitals have higher drug spending for commercially insured patients than non-340B hospitals and claims that it is the result of inappropriate drug use. However, methodological flaws in the study raise serious questions about the findings. In fact, Milliman’s report includes data that indicate … [Read more...]
340B Hospitals Turn Up Heat to Stop Deep Medicare Drug Payment Cuts
December 14, 2017—Hospitals in the 340B drug discount program are ramping up efforts to get Congress to block deep cuts in their Medicare Part B drug payments set to begin Jan. 1. In a Dec. 13 letter to the bipartisan leadership of Congress, 340B Health, which represents more than 1,300 hospitals and health systems in 340B, said the impending cuts “will cause tremendous … [Read more...]
Senator, Patient Advocate Support 340B in Hearing
December 13, 2017—Members of the Senate Health, Education, Labor, and Pensions (HELP) Committee heard a powerful defense of the 340B drug discount program yesterday at a hearing on the new National Academies of Sciences (NAS) report on why medicines cost so much and what can be done about it. The committee’s senior Democratic member, Sen. Patty Murray (D-Wash.), noted that … [Read more...]
Bipartisan Senate Group Asks Leaders to Help Block 340B Hospital Cuts
December 6, 2017—Efforts to block impending cuts to Medicare Part B payments to 340B hospitals gained momentum this week as a bipartisan group of six U.S. senators urged party leaders to enact legislation stopping the cuts before the end of December. The Dec. 5 letter from Sens. John Thune (R-S.D.), Rob Portman (R-Ohio), Shelley Moore Capito (R-W.Va.), Bill Nelson (D-Fla.), … [Read more...]
Senate Hearing Next Week on Outrageous Prescription Drug Prices
December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]